Jan Philipp Bewersdorf

Also affiliated with Yale Cancer Center, Yale University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 45 papers. Top paper: “E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial”.

E7820, an anti-cancer sulfonamide, degrades RBM39 in patients with splicing factor mutant myeloid malignancies: a phase II clinical trial

Leukemia(2023)10.1038/s41375-023-02050-4

N/A

0.982DataRank · unranked

52 citations

Maximilian Stahl, Justin Taylor, Xiaoli Mi, Namrata S. Chandhok, Justin M. Watts +11 more

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents

Annals of Hematology(2023)10.1007/s00277-023-05552-4

N/A

0.726DataRank · unranked

23 citations

Rory M. Shallis, Elad Sharon, Silvia Park, Rahul Ramaswamy, Caroline E. Roe +18 more

Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes

Annals of Hematology(2022)10.1007/s00277-021-04734-2

N/A

0.685DataRank · unranked

95 citations

Daniel J. DeAngelo, Jeanne Palmer, Christopher S. Seet, Martin S. Tallman, Xin Wei +8 more

Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells

Nature Biotechnology(2022)10.1038/s41587-022-01224-2

N/A

0.626DataRank · unranked

64 citations

Salima Benbarche, Bo Liu, Joseph Pangallo, Sisi Chen, Maximilian Stahl +15 more

Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1966788

N/A

0.574DataRank · unranked

45 citations

Andriy Derkach, Lohith Gowda, Kamal Menghrajani, Susan DeWolf, Josel D. Ruiz +27 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Cancers(2021)10.3390/cancers13071610

N/A

0.524DataRank · unranked

32 citations

Amer M. Zeidan, Jan Philipp Bewersdorf

Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.05.018

N/A

0.464DataRank · unranked

21 citations

Smith Giri, Rong Wang, Nikolai A. Podoltsev, Christina Williamson, Raajit K. Rampal +4 more

Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies

Leukemia(2025)10.1038/s41375-025-02515-8

N/A

0.396DataRank · unranked

13 citations

Xiaoli Mi, Bin Lü, Andrew Kuykendall, David A. Sallman, Manish R. Patel +16 more

Cost-Effectiveness Analyses in AML: What Have We Learned, How Should This Impact Patient Care, and What Needs to Be Done in the Future?

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.70012

N/A

0.330DataRank · unranked

8 citations

Scott F. Huntington, Amer M. Zeidan, Jan Philipp Bewersdorf

Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States

Blood Advances(2021)10.1182/bloodadvances.2021005642

N/A

0DataRank · unranked

12 citations

Stephanie Prozora, Nikolai A. Podoltsev, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze +4 more

Polo-like kinase inhibition as a therapeutic target in acute myeloid leukemia

Oncotarget(2021)10.18632/oncotarget.27919

N/A

0DataRank · unranked

4 citations

Amer M. Zeidan, Jan Philipp Bewersdorf

Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies

Clinical Lymphoma Myeloma & Leukemia(2021)10.1016/j.clml.2021.01.003

N/A

0DataRank · unranked

1 citations

Jan Philipp Bewersdorf, David M. Swoboda, Wei Wei, Lohith Gowda, Thomas Prébet +10 more

Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7045

N/A

0DataRank · unranked

0 citations

Amar H. Sheth, Shaurey Vetsa, Alyssa Grimshaw, Smith Giri, Nikolai A. Podoltsev +7 more

Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Blood(2022)10.1182/blood.2022015832

N/A

0DataRank · unranked

36 citations

Pierre Fenaux, Marco Gobbi, Jiřı́ Mayer, Gail J. Roboz, Jürgen Krauter +21 more

Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia

American Journal of Hematology(2022)10.1002/ajh.26757

N/A

0DataRank · unranked

25 citations

Andriy Derkach, Noushin Farnoud, Jan Philipp Bewersdorf, Troy M. Robinson, Christopher Famulare +35 more

Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia

Blood(2022)10.1182/blood.2021015325

N/A

0DataRank · unranked

24 citations

Taizo A. Nakano, Masaki Nomura, Hiromi Yamazaki, Jan Philipp Bewersdorf, Roger Mulet‐Lazaro +26 more

Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia

Blood(2022)10.1182/blood.2021014401

N/A

0DataRank · unranked

11 citations

Kishan Patel, George Goshua, Rory M. Shallis, Nikolai A. Podoltsev, Scott F. Huntington +2 more

Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic

Genes & Development(2022)10.1101/gad.349368.122

N/A

0DataRank · unranked

55 citations

Omar Abdel-Wahab, Jan Philipp Bewersdorf

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1st International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101072

N/A

0DataRank · unranked

18 citations

Zhuoer Xie, Rafael Bejar, Uma Borate, Jacqueline Boultwood, Andrew M. Brunner +37 more

Plasma renalase levels are associated with the development of acute pancreatitis

Pancreatology(2023)10.1016/j.pan.2023.01.001

N/A

0DataRank · unranked

4 citations

Frank Ulrich Weiß, Xiaojia Guo, Thomas R. Kolodecik, Jan Philipp Bewersdorf, Loren Laine +4 more

Risk prediction for clonal cytopenia: multicenter real-world evidence

Blood(2024)10.1182/blood.2024024756

N/A

0DataRank · unranked

50 citations

Rami S. Komrokji, Najla Al‐Ali, Alexandra Regelson, Susan Geyer, Anand Patel +39 more

Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Blood Cancer Journal(2024)10.1038/s41408-024-01000-2

N/A

0DataRank · unranked

31 citations

Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Sacchi de Camargo Correia Guilherme, Aaron D. Goldberg +12 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML

Blood Advances(2024)10.1182/bloodadvances.2024012858

N/A

0DataRank · unranked

12 citations

Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva J. Schaefer +18 more

Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1‐ or IDH2‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study

American Journal of Hematology(2024)10.1002/ajh.27366

N/A

0DataRank · unranked

9 citations

Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva J. Schaefer +18 more

Mis-splicing-derived neoantigens and cognate TCRs in splicing factor mutant leukemias

Cell(2025)10.1016/j.cell.2025.03.047

N/A

0DataRank · unranked

38 citations

Edie I. Crosse, Emma De Neef, Iñaki Etxeberría, Erich Sabio, Eric Wang +31 more

A niche driven mechanism determines response and a mutation-independent therapeutic approach for myeloid malignancies

Cancer Cell(2025)10.1016/j.ccell.2025.03.007

N/A

0DataRank · unranked

5 citations

Abdullah Mahmood Ali, Rossella Labella, Brygida Bisikirska, Álvaro Cuesta‐Domínguez, Paraskevi Vgenopoulou +29 more

Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis

Blood Advances(2025)10.1182/bloodadvances.2025017611

N/A

0DataRank · unranked

2 citations

Naira Link Woite, Benjamin Rolles, Jessica M. Stempel, Alain Mina, Lourdes Mendez +7 more

Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML

Blood Advances(2025)10.1182/bloodadvances.2025016532

N/A

0DataRank · unranked

1 citations

Kishan Patel, Nikolai A. Podoltsev, Tariq Kewan, Jessica M. Stempel, Lourdes Mendez +8 more

Second malignancies among older patients with classical myeloproliferative neoplasms treated with ruxolitinib

Blood Neoplasia(2025)10.1016/j.bneo.2025.100159

N/A

0DataRank · unranked

0 citations

Jessica M. Stempel, Rory M. Shallis, Scott F. Huntington, Amer M. Zeidan, Natalia Neparidze +6 more

Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?

Cells(2020)10.3390/cells9102310

N/A

0DataRank · unranked

102 citations

Amer M. Zeidan, Jan Philipp Bewersdorf

Acute myeloid leukemia after myeloproliferative neoplasms: Real‐world outcomes in the new treatment era in the United States

Cancer(2026)10.1002/cncr.70415

N/A

0DataRank · unranked

0 citations

Rong Wang, Lourdes Mendez, Alain Mina, Luis E. Aguirre, Maximilian Stahl +4 more

Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and meta-analysis

Haematologica(2020)10.3324/haematol.2019.242826

N/A

0DataRank · unranked

99 citations

Smith Giri, Rong Wang, Robert T. Williams, Martin S. Tallman, Amer M. Zeidan +2 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

Interferon alpha therapy in essential thrombocythemia and polycythemia vera—a systematic review and meta-analysis

Leukemia(2020)10.1038/s41375-020-01020-4

N/A

0DataRank · unranked

70 citations

Smith Giri, Rong Wang, Nikolai A. Podoltsev, Robert T. Williams, Martin S. Tallman +4 more

Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia—A systematic review and meta‐analysis

Transfusion(2020)10.1111/trf.15994

N/A

0DataRank · unranked

64 citations

Smith Giri, Martin S. Tallman, Amer M. Zeidan, Maximilian Stahl, Jan Philipp Bewersdorf

Randomized trials with checkpoint inhibitors in acute myeloid leukaemia and myelodysplastic syndromes: What have we learned so far and where are we heading?

Best Practice & Research Clinical Haematology(2020)10.1016/j.beha.2020.101222

N/A

0DataRank · unranked

10 citations

Amer M. Zeidan, Jan Philipp Bewersdorf

No child with a transfusion-dependent haemoglobinopathy left unchelated: are we there yet?

The Lancet Haematology(2020)10.1016/s2352-3026(20)30114-9

N/A

0DataRank · unranked

0 citations

Alì Taher, Amer M. Zeidan, Jan Philipp Bewersdorf

Management of patients with higher-risk myelodysplastic syndromes after failure of hypomethylating agents: What is on the horizon?

Best Practice & Research Clinical Haematology(2021)10.1016/j.beha.2021.101245

N/A

0DataRank · unranked

26 citations

Amer M. Zeidan, Jan Philipp Bewersdorf

Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation–A Systematic Review and Meta-Analysis

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.09.005

N/A

0DataRank · unranked

31 citations

Cecily Allen, Abu‐Sayeef Mirza, Alyssa Grimshaw, Smith Giri, Nikolai A. Podoltsev +6 more

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis—A Systematic Review and Meta-Analysis

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.016

N/A

0DataRank · unranked

20 citations

Amar H. Sheth, Shaurey Vetsa, Alyssa Grimshaw, Smith Giri, Nikolai A. Podoltsev +7 more

Clinical Management of Anemia in Patients with Myelodysplastic Syndromes: An Update on Emerging Therapeutic Options

Cancer Management and Research(2021)10.2147/cmar.s240600

N/A

0DataRank · unranked

17 citations

Jan Philipp Bewersdorf, Amer M. Zeidan, Russell S. Lewis